MedTrace Logo

Intracoronary Autologous Stem Cell Transplantation in ST Elevation Myocardial Infarction: TRACIA STUDY.

NCT00725738 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2008-07-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate the ejection fraction (EF) increase at 6 months follow up and major adverse cardiovascular events (MACE) after intracoronary autologous stem cell transplantation in ST elevation myocardial infarction patients versus a control group.

Conditions

  • Acute Myocardial Infarction

Interventions

GENETIC

Stem Cell Transplantation

1-2 million of CD34 cells injected through the infarct related artery by PTCA "over-the-wire" catheter during multiple sequences of balloon artery occlusion with a mean duration of 30 minutes.

Sponsors & Collaborators

  • National Center of Blood Transfusion Mexico.

    collaborator UNKNOWN

  • National Heart Institute, Mexico

    lead OTHER_GOV

Principal Investigators

  • Marco A Peña-Duque, MD · National Institute of Cardiology "Ignacio Chávez" Mexico

  • Marco A Peña-Duque, MD · National Institute of Cardiology "Ignacio Chávez" Mexico

  • Marco A Peña-Duque, MD · National Institute of Cardiology "Ignacio Chávez" Mexico

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00725738 on ClinicalTrials.gov